FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $58,420 | +2109.5% | 10,160 | +2478.7% | 0.00% | – |
| Q1 2024 | $2,644 | -73.2% | 394 | -74.2% | 0.00% | – |
| Q4 2023 | $9,849 | -60.0% | 1,527 | -69.0% | 0.00% | -100.0% |
| Q3 2023 | $24,605 | +184.4% | 4,921 | +300.4% | 0.00% | – |
| Q2 2023 | $8,653 | +57586.7% | 1,229 | -48.0% | 0.00% | – |
| Q1 2023 | $15 | +87.5% | 2,364 | +88.8% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 1,252 | -66.0% | 0.00% | -100.0% |
| Q3 2022 | $31,000 | +19.2% | 3,687 | +92.0% | 0.00% | 0.0% |
| Q2 2022 | $26,000 | +85.7% | 1,920 | +114.8% | 0.00% | – |
| Q1 2022 | $14,000 | -64.1% | 894 | -48.4% | 0.00% | -100.0% |
| Q4 2021 | $39,000 | +254.5% | 1,734 | +111.2% | 0.00% | – |
| Q3 2021 | $11,000 | -26.7% | 821 | -41.3% | 0.00% | – |
| Q2 2021 | $15,000 | -42.3% | 1,399 | -28.9% | 0.00% | – |
| Q1 2021 | $26,000 | +188.9% | 1,967 | +349.1% | 0.00% | – |
| Q4 2020 | $9,000 | – | 438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $10,822,000 | 10.05% |
| Flagship Pioneering Inc. | 12,674,120 | $108,744,000 | 4.58% |
| Birchview Capital, LP | 264,843 | $2,272,000 | 1.60% |
| Artal Group S.A. | 1,720,720 | $14,764,000 | 0.63% |
| Rockwood Wealth Management, LLC | 124,030 | $1,064,178 | 0.34% |
| Alphabet Inc. | 500,901 | $4,298,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $6,671,000 | 0.13% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 330,051 | $2,832,000 | 0.04% |
| Virtus ETF Advisers LLC | 8,258 | $71,000 | 0.03% |
| Point72 Asset Management, L.P. | 388,600 | $3,334,000 | 0.01% |